Offer - Urjas Oil for just ₹ 1 X
Geficad, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Non-Small Cell Lung Cancer. Geficad also has some secondary and off-label uses. These are listed below.
The optimal dosage of Geficad is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Common side effects of Geficad include Weakness, Dry Skin, Dark colored (brown) urine. Apart from the aforementioned side effects, Geficad can also lead to other problems, which have been listed below. Normally, these side effects of Geficad are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Geficad is Severe for pregnant women and Severe for women who are breastfeeding. It is important to know if Geficad has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Geficad related warnings section.
Geficad can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Geficad in conditions like Liver Disease, Gastritis. Some other conditions that can be affected by Geficad are listed in the contraindications section below.
Besides this, Geficad may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to the above precautions for Geficad, it is important to know that it is not safe while driving, and is not habit-forming.
Geficad is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Geficad safe for pregnant women?
Geficad shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Geficad safe during breastfeeding?
Geficad should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Geficad on the Kidneys?
Very few cases of side effects of Geficad on kidney have been reported.
What is the effect of Geficad on the Liver?
Side effects of Geficad rarely affect the liver.
What is the effect of Geficad on the Heart?
Using Geficad does not have any harmful effects on the heart.
Geficad should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Geficad unless your doctor advises you to do so -
Is this Geficad habit forming or addictive?
No, there is no any evidence that Geficad is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Geficad, you should not drive or work on any heavy machine, as Geficad can make you drowsy.
Is it safe?
Yes, but consume Geficad only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Geficad for mental disorders.
Interaction between Food and Geficad
Taking Geficad with food is safe.
Interaction between Alcohol and Geficad
No research has been done on this till date. Therefore, it is not known what the effect of taking Geficad with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Iressa (gefitinib tablets)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 870
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 610-612